Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABP-745 by Jiangsu Atom Bioscience and Pharmaceutical for Gouty Arthritis (Gout): Likelihood of Approval
ABP-745 is under clinical development by Jiangsu Atom Bioscience and Pharmaceutical and currently in Phase I for Gouty Arthritis (Gout)....